PUBLISHER: 360iResearch | PRODUCT CODE: 1591929
PUBLISHER: 360iResearch | PRODUCT CODE: 1591929
Hydrogel-based Drug Delivery System Market by Delivery Route (Ocular, Oral Cavity, Subcutaneous), Polymer Origin (Hybrid, Natural, Synthetic) - Global Forecast 2025-2030
The Hydrogel-based Drug Delivery System Market was valued at USD 7.51 billion in 2023, expected to reach USD 8.15 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 13.42 billion by 2030.
The scope of hydrogel-based drug delivery systems encompasses an innovative approach to medication administration, capitalizing on the biocompatibility and high water content of hydrogels to facilitate controlled and sustained drug release. These systems are crucial because they enhance therapeutic efficacy, reduce side effects, and improve patient compliance by optimizing drug distribution. The application of hydrogel-based drug delivery technology spans across diverse areas, including transdermal patches, ocular systems, oral delivery, and implantable devices, catering to pharmaceuticals targeting cancer, diabetes, and autoimmune diseases, among others. In terms of end-use, these systems are predominantly employed by pharmaceutical companies, research institutes, and hospitals.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 7.51 billion |
| Estimated Year [2024] | USD 8.15 billion |
| Forecast Year [2030] | USD 13.42 billion |
| CAGR (%) | 8.65% |
Market growth is significantly influenced by factors such as increasing prevalence of chronic diseases, advancements in hydrogel technology, and rising demand for targeted drug delivery methods. Key opportunities in the sector include the development of personalized medicine options and expanding applications in gene and protein therapy, driven by ongoing advancements in biotechnology and material science. Market players can seize these opportunities by investing in research to enhance hydrogel properties, focusing on smart hydrogels that respond to environmental stimuli like temperature and pH.
However, challenges such as the high cost of development, regulatory hurdles, and potential biocompatibility issues pose barriers to market expansion. Addressing these challenges requires strategic collaboration with regulatory bodies to streamline approval processes and rigorous R&D to ensure safety and efficacy. Best areas of innovation include exploring bioresorbable hydrogels and multimodal drug-loaded hydrogels to diversify therapeutic applications.
The market is dynamic, characterized by continuous technological breakthroughs and a competitive landscape with intense R&D activities. Companies aiming for business growth should focus on partnerships and collaborations for technology exchange, while keeping abreast of emerging trends, such as 3D bioprinting with hydrogel matrices and investing in robust clinical trials to validate novel applications.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hydrogel-based Drug Delivery System Market
The Hydrogel-based Drug Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Rising upsurge in the need of targeted controlled drug delivery (TCDD)
- Hydrogel owing to its excellent physical properties
- Market Restraints
- Low mechanical strength, and compatibility issues
- Market Opportunities
- Increasing investment and funding by leading pharma companies in R&D activities
- Need of Improved biocompatibility and biodegradability technologies for drug manufacturing
- Market Challenges
- High cost of hydrogels
Porter's Five Forces: A Strategic Tool for Navigating the Hydrogel-based Drug Delivery System Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hydrogel-based Drug Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Hydrogel-based Drug Delivery System Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hydrogel-based Drug Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Hydrogel-based Drug Delivery System Market
A detailed market share analysis in the Hydrogel-based Drug Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hydrogel-based Drug Delivery System Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hydrogel-based Drug Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Hydrogel-based Drug Delivery System Market
A strategic analysis of the Hydrogel-based Drug Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Hydrogel-based Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Akorn, Incorporated, Ashland, B. Braun Holding GmbH & Co. KG, Bausch and Lomb, Blairex Laboratories, Inc., Cardinal Health, Endo International plc, Ferring B.V., GALDERMA, Johnson & Johnson, Medline Industries, Medtronic, Ocular Therapeutix, Inc., Paul Hartmann, Smith & Nephew plc., The Cooper Companies, and Tolmar Pharmaceuticals, Inc.
Market Segmentation & Coverage
This research report categorizes the Hydrogel-based Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Delivery Route, market is studied across Ocular, Oral Cavity, Subcutaneous, and Topical.
- Based on Polymer Origin, market is studied across Hybrid, Natural, and Synthetic.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising upsurge in the need of targeted controlled drug delivery (TCDD)
- 5.1.1.2. Hydrogel owing to its excellent physical properties
- 5.1.2. Restraints
- 5.1.2.1. Low mechanical strength, and compatibility issues
- 5.1.3. Opportunities
- 5.1.3.1. Increasing investment and funding by leading pharma companies in R&D activities
- 5.1.3.2. Need of Improved biocompatibility and biodegradability technologies for drug manufacturing
- 5.1.4. Challenges
- 5.1.4.1. High cost of hydrogels
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Hydrogel-based Drug Delivery System Market, by Delivery Route
- 6.1. Introduction
- 6.2. Ocular
- 6.3. Oral Cavity
- 6.4. Subcutaneous
- 6.5. Topical
7. Hydrogel-based Drug Delivery System Market, by Polymer Origin
- 7.1. Introduction
- 7.2. Hybrid
- 7.3. Natural
- 7.4. Synthetic
8. Americas Hydrogel-based Drug Delivery System Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Hydrogel-based Drug Delivery System Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Hydrogel-based Drug Delivery System Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. 3M Company
- 2. Akorn, Incorporated
- 3. Ashland
- 4. B. Braun Holding GmbH & Co. KG
- 5. Bausch and Lomb
- 6. Blairex Laboratories, Inc.
- 7. Cardinal Health
- 8. Endo International plc
- 9. Ferring B.V.
- 10. GALDERMA
- 11. Johnson & Johnson
- 12. Medline Industries
- 13. Medtronic
- 14. Ocular Therapeutix, Inc.
- 15. Paul Hartmann
- 16. Smith & Nephew plc.
- 17. The Cooper Companies
- 18. Tolmar Pharmaceuticals, Inc
LIST OF FIGURES
- FIGURE 1. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
- FIGURE 2. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 11. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 13. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 19. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET DYNAMICS
- TABLE 7. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY OCULAR, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORAL CAVITY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 19. ARGENTINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 20. ARGENTINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 21. BRAZIL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 22. BRAZIL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 23. CANADA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 24. CANADA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 25. MEXICO HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 26. MEXICO HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 27. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 28. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 29. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 30. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 31. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 32. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 33. AUSTRALIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 34. AUSTRALIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 35. CHINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 36. CHINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 37. INDIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 38. INDIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 39. INDONESIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 40. INDONESIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 41. JAPAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 42. JAPAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 43. MALAYSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 44. MALAYSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 45. PHILIPPINES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 46. PHILIPPINES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 47. SINGAPORE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 48. SINGAPORE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 49. SOUTH KOREA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 50. SOUTH KOREA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 51. TAIWAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 52. TAIWAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 53. THAILAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 54. THAILAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 55. VIETNAM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 56. VIETNAM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 57. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 58. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 59. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 60. DENMARK HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 61. DENMARK HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 62. EGYPT HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 63. EGYPT HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 64. FINLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 65. FINLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 66. FRANCE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 67. FRANCE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 68. GERMANY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 69. GERMANY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 70. ISRAEL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 71. ISRAEL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 72. ITALY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 73. ITALY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 74. NETHERLANDS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 75. NETHERLANDS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 76. NIGERIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 77. NIGERIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 78. NORWAY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 79. NORWAY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 80. POLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 81. POLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 82. QATAR HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 83. QATAR HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 84. RUSSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 85. RUSSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 86. SAUDI ARABIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 87. SAUDI ARABIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 88. SOUTH AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 89. SOUTH AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 90. SPAIN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 91. SPAIN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 92. SWEDEN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 93. SWEDEN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 94. SWITZERLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 95. SWITZERLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 96. TURKEY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 97. TURKEY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 98. UNITED ARAB EMIRATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 99. UNITED ARAB EMIRATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 100. UNITED KINGDOM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
- TABLE 101. UNITED KINGDOM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
- TABLE 102. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 103. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
